Lori Woods - IsoRay Interim Chief Executive Officer, Director
CEO
Ms. Lori A. Woods is a Chief Executive Officer, Director of IsoRay, Inc. she was an Interim Chief Executive Officer of the Company. Ms. Woods has over 30 years experience in medical device technology and healthcare services, serving in numerous senior capacities. In July 2006, Ms. Woods joined IsoRay as a Vice President. Ms. Woods was appointed Acting Chief Operating Officer of the Company in February 2008, and then appointed Chief Operating Officer on February 18, 2009, a position she held until January 2010. Immediately prior to her appointment as interim CEO, beginning in February 2016, Ms. Woods served as a consultant to the Company. Prior to her work as a consultant to the Company, Ms. Woods held various leadership positions in multiple closely held companies in the medical device and services space since 2018.
| Age | 55 |
| Tenure | 7 years |
| Phone | 509 375 1202 |
| Web | https://isoray.com |
IsoRay Management Efficiency
The company has Return on Asset of (0.1085) % which means that on every $100 spent on assets, it lost $0.1085. This is way below average. In the same way, it shows a return on shareholders' equity (ROE) of (0.1741) %, meaning that it generated no profit with money invested by stockholders. IsoRay's management efficiency ratios could be used to measure how well IsoRay manages its routine affairs as well as how well it operates its assets and liabilities.Similar Executives
| Found 2 records | CEO Age | ||
| Bradley Soultz | Willscot Mobile Mini | 56 | |
| Jason Fox | Net Lease Office | 52 | |
Management Performance
| Return On Equity | -0.17 | |||
| Return On Asset | -0.11 |
IsoRay Inc Leadership Team
Elected by the shareholders, the IsoRay's board of directors comprises two types of representatives: IsoRay inside directors who are chosen from within the company, and outside directors, selected externally and held independent of IsoRay. The board's role is to monitor IsoRay's management team and ensure that shareholders' interests are well served. IsoRay's inside directors are responsible for reviewing and approving budgets prepared by upper management to implement core corporate initiatives and projects. On the other hand, IsoRay's outside directors are responsible for providing unbiased perspectives on the board's policies.
| Mark Austin, Principal Accounting Officer, Co-Principal Financial Officer, Controller | ||
| Alan Hoffmann, Independent Director | ||
| Lisa Lauer, Vice President - Business Development | ||
| Lori Woods, Interim Chief Executive Officer, Director | ||
| Michael McCormick, Independent Chairman of the Board | ||
| Jonathan Hunt, Chief Financial Officer, Co-Principal Financial Officer | ||
| William Cavanagh, Vice President - Research and Development | ||
| Lori HolmesWoods, CEO Director | ||
| Michael Krachon, Vice President, Director of Sales and Marketing | ||
| Jennifer Streeter, Interim Chief Operating Officer, Vice President of Human Resources | ||
| Mark CPA, Controller, Fin | ||
| William III, Chief Officer | ||
| Philip Vitale, Independent Director | ||
| Krista Cline, Senior Director of Operations, Corporate Secretary |
IsoRay Stock Performance Indicators
The ability to make a profit is the ultimate goal of any investor. But to identify the right stock is not an easy task. Is IsoRay a good investment? Although profit is still the single most important financial element of any organization, multiple performance indicators can help investors identify the equity that they will appreciate over time.
| Return On Equity | -0.17 | |||
| Return On Asset | -0.11 | |||
| Profit Margin | (1.16) % | |||
| Operating Margin | (1.21) % | |||
| Current Valuation | (11.02 M) | |||
| Shares Outstanding | 278.66 M | |||
| Shares Owned By Insiders | 0.76 % | |||
| Shares Owned By Institutions | 6.18 % | |||
| Number Of Shares Shorted | 409.25 K | |||
| Price To Earning | (5.00) X |
Pair Trading with IsoRay
One of the main advantages of trading using pair correlations is that every trade hedges away some risk. Because there are two separate transactions required, even if IsoRay position performs unexpectedly, the other equity can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in IsoRay will appreciate offsetting losses from the drop in the long position's value.The ability to find closely correlated positions to Biogen could be a great tool in your tax-loss harvesting strategies, allowing investors a quick way to find a similar-enough asset to replace Biogen when you sell it. If you don't do this, your portfolio allocation will be skewed against your target asset allocation. So, investors can't just sell and buy back Biogen - that would be a violation of the tax code under the "wash sale" rule, and this is why you need to find a similar enough asset and use the proceeds from selling Biogen Inc to buy it.
The correlation of Biogen is a statistical measure of how it moves in relation to other instruments. This measure is expressed in what is known as the correlation coefficient, which ranges between -1 and +1. A perfect positive correlation (i.e., a correlation coefficient of +1) implies that as Biogen moves, either up or down, the other security will move in the same direction. Alternatively, perfect negative correlation means that if Biogen Inc moves in either direction, the perfectly negatively correlated security will move in the opposite direction. If the correlation is 0, the equities are not correlated; they are entirely random. A correlation greater than 0.8 is generally described as strong, whereas a correlation less than 0.5 is generally considered weak.
Correlation analysis and pair trading evaluation for Biogen can also be used as hedging techniques within a particular sector or industry or even over random equities to generate a better risk-adjusted return on your portfolios.Check out Risk vs Return Analysis to better understand how to build diversified portfolios. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in state. You can also try the Idea Optimizer module to use advanced portfolio builder with pre-computed micro ideas to build optimal portfolio .
Other Consideration for investing in IsoRay Stock
If you are still planning to invest in IsoRay Inc check if it may still be traded through OTC markets such as Pink Sheets or OTC Bulletin Board. You may also purchase it directly from the company, but this is not always possible and may require contacting the company directly. Please note that delisted stocks are often considered to be more risky investments, as they are no longer subject to the same regulatory and reporting requirements as listed stocks. Therefore, it is essential to carefully research the IsoRay's history and understand the potential risks before investing.
| Instant Ratings Determine any equity ratings based on digital recommendations. Macroaxis instant equity ratings are based on combination of fundamental analysis and risk-adjusted market performance | |
| Alpha Finder Use alpha and beta coefficients to find investment opportunities after accounting for the risk | |
| Equity Valuation Check real value of public entities based on technical and fundamental data | |
| Portfolio Comparator Compare the composition, asset allocations and performance of any two portfolios in your account | |
| Top Crypto Exchanges Search and analyze digital assets across top global cryptocurrency exchanges | |
| Positions Ratings Determine portfolio positions ratings based on digital equity recommendations. Macroaxis instant position ratings are based on combination of fundamental analysis and risk-adjusted market performance | |
| Commodity Channel Use Commodity Channel Index to analyze current equity momentum | |
| Money Managers Screen money managers from public funds and ETFs managed around the world |